Enfusion Appoints Oleg Movchan Interim Chief Executive Officer

Author's Avatar
Aug 22, 2022

Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-based investment management software and services, today announced that its Board of Directors (the “Board”) has appointed Oleg+Movchan, currently a member of the Board, as Interim Chief Executive Officer, effective August 21, 2022. Mr. Movchan succeeds Thomas Kim, who has resigned as CEO and as a Director of the Company so that he can spend more time with his family.